Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Petros Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2024 was -280.1%. For fiscal 2024 it was -280.1%, against -140.2% the year before. The highest annual figure on record is -115.0% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -280.1% | −139.9 |
| FY2023 | Dec 31, 2023 | -140.2% | +194.2 |
| FY2022 | Dec 31, 2022 | -334.4% | −219.4 |
| FY2021 | Dec 31, 2021 | -115.0% | +100.3 |
| FY2020 | Dec 31, 2020 | -215.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -1278.4% | −1006.7 |
| Q3 FY2024 | Sep 30, 2024 | -140.9% | −13.2 |
| Q2 FY2024 | Jun 30, 2024 | -46.6% | +8.4 |
| Q1 FY2024 | Mar 31, 2024 | -155.7% | +373.2 |
| Q3 FY2023 | Sep 30, 2023 | -271.7% | −228.4 |
| Q2 FY2023 | Jun 30, 2023 | -127.7% | −120.6 |
| Q1 FY2023 | Mar 31, 2023 | -55.0% | +31.0 |
| Q4 FY2022 | Dec 31, 2022 | -528.9% | −602.8 |
| Q2 FY2022 | Jun 30, 2022 | -43.3% | +142.4 |
| Q1 FY2022 | Mar 31, 2022 | -7.1% | +88.2 |
| Q2 FY2021 | Jun 30, 2021 | -86.0% | +333.7 |
| Q1 FY2021 | Mar 31, 2021 | 73.8% | +413.3 |
| Q4 FY2020 | Dec 31, 2020 | -185.6% | – |
| Q3 FY2020 | Sep 30, 2020 | -95.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -419.7% | – |
| Q1 FY2020 | Mar 31, 2020 | -339.5% | – |
See a number that looks wrong?